Navigation Links
CYPHER(R) Sirolimus Drug-Eluting Stent Remains Unsurpassed in Terms of Clinical Safety and Efficacy
Date:9/30/2010

t"> var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ''; var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var key in first_result) { //s += key + ":" + first_result[key].toString() + "
"; if(key == "shortUrl") { shortURL = first_result[key].toString(); break; } } PostTwitter(); } function readCookie(name){ var cookieValue = ""; var search = name + "="; if(document.cookie.length > 0){ offset = document.cookie.indexOf(search); if (offset != -1){ offset += search.length; end = document.cookie.indexOf(";", offset); if (end == -1) end = document.cookie.length; cookieValue = unescape(document.cookie.substring(offset, end)) } } return cookieValue; } window.onload=function(){ OnNewsreleaseLoad(); var userid = readCookie('DMUserTrack'); var csid = 104064943; var newstogramURL = 'http://www.prnewswire.com/templates/PRN_MultiVu_URL_Reader?userid='+userid+'&csid='+csid; //var newstogramURL ='http://www.prnewswire.com/templates/prnwConfig.xml'; var delay = function() { sendToFlash('StartPlay',newstogramURL); }; setTimeout(delay,100,"JavaScript"); //setTimeout("sendToFlash('StartPlay', 'http://www.prnewswire.com/templates/prnwConfig.xml')",100); }; function ShortenURL() { //Bit.ly function call to shorten url BitlyClient.call('shorten', {'longUrl': formatURL()}, 'BitlyCB.alertResponse'); }

SOURCE Cordis Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
2. Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent
3. OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial
4. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
5. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
6. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
7. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
8. Patient Enrollment Completed in First Randomized Clinical Study of OrbusNeichs Combo™ Bio-engineered Sirolimus Eluting Stent
9. Pre-clinical Data Show OrbusNeichs Combo Bio-engineered Sirolimus Eluting Stent May Offer Advantages to Current Drug Eluting Stent Technologies
10. MacuSight(TM) Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration
11. MacuSight(TM) Announces Positive Initial Results From Phase 1 Study of Sirolimus in Diabetic Macular Edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 2015  EP Global Communications, Inc. (OTC-PINK: EPGL) In ... opened negotiations with CooperVision, Inc. at $1.1 billion ... ophthalmic technologies. As previously disclosed publicly, CooperVision, Inc. ... contact lens technologies, which has led to several ... industry experts that just one of these newly ...
(Date:3/30/2015)... AUSTIN, Texas , March 30, 2015 ... highlight the My Diabetes Emergency Plan at the 2015 ... encourage you to be prepared to manage your #diabetes ... of Endocrinology (ACE) – the charitable, educational and scientific ... – has joined forces with Lilly Diabetes to share ...
(Date:3/30/2015)... DUBLIN , Mar. 26, 2015 Research ... announced the addition of the "Computer Aided ... report to their offering. Annual estimates ... through 2020. Also, a six-year historic analysis is ... are derived from primary and secondary research. Company ...
Breaking Medicine Technology:CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B 2CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B 3Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 2Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 3Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 4
... Digestive Disease Week (DDW), SAN DIEGO, May ... Digestive Disease Week reaffirm the long-term, sustainable,efficacy and ... in,treating patients with moderate to severe Crohn,s disease. ... responders and the remission,rate remained stable in many ...
... US Employer Claims Suggests a Benefit,of Anti-Tumor Necrosis Factor Therapies on ... ... 20 Data from a new analysis of the,Active Ulcerative Colitis ... than 60 percent of patients with moderately to severely active,ulcerative colitis ...
Cached Medicine Technology:Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 2Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 3Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 4Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 5Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 6Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 7Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 8New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 2New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 3New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 4New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 5New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 6New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 7New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 8
(Date:3/30/2015)... TX (PRWEB) March 30, 2015 Healthy, ... to MedX Pharmacy. The staff of pharmacists is specially ... care issues like acne, eczema and other conditions. , ... with a patient’s dermatologist and/or PCP to tackle most ... pharmacy, MedX Pharmacy has employed specialty-trained pharmacists who have ...
(Date:3/30/2015)... 2015 In a recent report published ... Chris Christie is championing effective drug and alcohol treatment ... scrambling to recover funds to stabilize the addiction treatment ... victims of drug and alcohol addiction. Harbor Village Detox ... by substance use disorders in New Jersey, in hopes ...
(Date:3/30/2015)... 30, 2015 Follow us on ... to develop and establish chronic pain rehabilitation centers are ... the market is poised to benefit from the rise ... the increase in chronic health conditions such as Cancer, ... among others. While conventional treatment for pain management is ...
(Date:3/30/2015)... March 30, 2015 Recently, 10 Best ... Water Awards, with the top three winners being Fiji water, ... the company’s website, along with other informative information about water. ... water, spring water, mineral water and sparkling water are among ... of the top exotic water brands highlighted on the ...
(Date:3/30/2015)... Valerie Harper, the actress best known ... “The Mary Tyler Moore Show,” will be the keynote ... CURETM magazine announced today. Harper, who is living with ... Society’s 40th Annual Congress on April 23 in Orlando, ... nurses play in the lives of people with cancer. ...
Breaking Medicine News(10 mins):Health News:MedX Pharmacy Offers Skin Care Tips 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Best Exotic Water Brands Acclaimed by 10 Best Water 2Health News:Spunky Sitcom Star and Lung Cancer Survivor Valerie Harper to Keynote Extraordinary Healer™ Award Ceremony Honoring Oncoloy Nurses 2Health News:Spunky Sitcom Star and Lung Cancer Survivor Valerie Harper to Keynote Extraordinary Healer™ Award Ceremony Honoring Oncoloy Nurses 3
... Observance To Draw Attention To "The Sneak Thief of Sight" ... effort to combat one of the leading causes of blindness ... Organization have set March 12, 2009, as the second ... by awareness and educational events organized by eye care institutions ...
... neuroscience and oncology to OAPI, further strengthening the ... , ROCKVILLE, Md. and PRINCETON, N.J., Feb. ... fast-growing health care company that commercializes Otsuka-discovered and ... the appointment of Mark Altmeyer as President and ...
... (NYSE Alternext US: CUR) announced today that James ... the People,s Republic of China, has joined the ... advisor on China. (Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO )Senator ... from Tennessee in 1976 where he served for ...
... results -LAVAL, QC, Feb. 12 /PRNewswire-FirstCall/ - Labopharm Inc. ... that it will host a conference call on Thursday, ... fourth quarter 2008 financial results. Labopharm will report its ... approximately 7:00 a.m. the same day. , To access ...
... largest,integrative wellness centre of its kind in the world, ... will offer the most comprehensive,array of world-class medical treatments, ... is already a popular lifestyle and leisure,destination, can soon ... the opening,of the MaloClinicSPA in mid 2009. , ...
... Will Now Be Available to a Wider Medical Market through Nation,s ... ... 2009 -- Inviro Medical Devices, an industry leader in infection control ... of the nation,s largest and most respected GPOs, or group provider ...
Cached Medicine News:Health News:World Glaucoma Day Set For March 12, 2009 2Health News:World Glaucoma Day Set For March 12, 2009 3Health News:World Glaucoma Day Set For March 12, 2009 4Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 2Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 3Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 4Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 5Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 6Health News:Senator James Sasser, Former Ambassador to China, Joins Neuralstem Advisory Board 2Health News:Senator James Sasser, Former Ambassador to China, Joins Neuralstem Advisory Board 3Health News:Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET) 2Health News:Medical Tourism Comes to Macao -- World's Largest Integrative One-Stop Wellness Centre MaloClinicSPA Opens at The Venetian(R) Macao-Resort-Hotel 2Health News:Medical Tourism Comes to Macao -- World's Largest Integrative One-Stop Wellness Centre MaloClinicSPA Opens at The Venetian(R) Macao-Resort-Hotel 3Health News:Medical Tourism Comes to Macao -- World's Largest Integrative One-Stop Wellness Centre MaloClinicSPA Opens at The Venetian(R) Macao-Resort-Hotel 4Health News:Medical Tourism Comes to Macao -- World's Largest Integrative One-Stop Wellness Centre MaloClinicSPA Opens at The Venetian(R) Macao-Resort-Hotel 5Health News:Medical Tourism Comes to Macao -- World's Largest Integrative One-Stop Wellness Centre MaloClinicSPA Opens at The Venetian(R) Macao-Resort-Hotel 6Health News:Medical Tourism Comes to Macao -- World's Largest Integrative One-Stop Wellness Centre MaloClinicSPA Opens at The Venetian(R) Macao-Resort-Hotel 7Health News:Inviro Medical Devices Is Awarded a Three Year Contract with Leading GPO Novation 2
... Plus Chemistry Analyzer is an in vitro ... of clinical chemistry parameters using Reflotron Test Tabs. ... and ensures rapid and reliable results while being ... clear LC display and the profile can be ...
... ASR contains primers and a FAM-labeled probe targeting ... the Parvo B19 ASR contains primers and a ... This ASR requires an instrument that can detect ... System., The Cepheid Analyte Specific Reagent* (ASR) program ...
... Enterovirus ASR contains primers, a FAM-labeled probe and ... detect a 115 bp region of the 5' ... detect FAM, Alexa 532 and Texas Red reporter ... Analyte Specific Reagent* (ASR) program is comprised of ...
... The B. pertussis ASR contains primers and ... a 103 bp region of the IS481 gene. ... a Texas Red-labeled probe and DNA for an ... that can detect FAM and Texas Red reporter ...
Medicine Products: